Variant report

Variant	esv3362076
Chromosome Location	chr7:16170527-16175225
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr7:16163332..16166682-chr7:16168579..16171460,3	K562	blood:
2	chr7:16174593..16177204-chr7:16180297..16182169,2	K562	blood:

Extended variants
information (count: 144 )
Associated
traits (count: 89 )

Variant overlapped rSNPs/rCNVs (count:144 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs532420599	chr7:16170530-16170531	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs548072746	chr7:16170659-16170660	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs560097297	chr7:16170681-16170682	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs530270212	chr7:16170685-16170686	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs548846256	chr7:16170723-16170724	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs567240159	chr7:16170726-16170727	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs537974492	chr7:16170735-16170736	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs139846379	chr7:16170750-16170751	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs28386896	chr7:16170796-16170797	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs538257439	chr7:16170808-16170809	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs531442813	chr7:16170833-16170834	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs115661118	chr7:16170845-16170846	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs572057827	chr7:16170861-16170862	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs116144452	chr7:16170890-16170891	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs564587473	chr7:16170899-16170900	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs117227421	chr7:16170906-16170907	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs543868816	chr7:16170920-16170921	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs558796918	chr7:16170974-16170975	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs577126536	chr7:16171009-16171010	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs541438787	chr7:16171055-16171056	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs191306198	chr7:16171062-16171063	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs1358280	chr7:16171065-16171066	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs542419890	chr7:16171141-16171142	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs567810962	chr7:16171144-16171145	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs563877920	chr7:16171167-16171168	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs531028574	chr7:16171179-16171180	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs549808082	chr7:16171181-16171182	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs117749176	chr7:16171183-16171184	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs533000446	chr7:16171234-16171235	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs76357720	chr7:16171268-16171269	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs547027992	chr7:16171271-16171272	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs565621057	chr7:16171308-16171309	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs188237385	chr7:16171364-16171365	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs73056339	chr7:16171376-16171377	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs192801635	chr7:16171387-16171388	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs538486949	chr7:16171425-16171426	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs558964072	chr7:16171441-16171442	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs577462462	chr7:16171444-16171445	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs117266697	chr7:16171457-16171458	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs184906450	chr7:16171489-16171490	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs189833091	chr7:16171494-16171495	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs542505807	chr7:16171527-16171528	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs557081655	chr7:16171543-16171544	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs531085009	chr7:16171544-16171545	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs546125990	chr7:16171558-16171559	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs536129048	chr7:16171567-16171568	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs532107799	chr7:16171578-16171579	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs549952764	chr7:16171585-16171586	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs181594524	chr7:16171589-16171590	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs565311178	chr7:16171654-16171655	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:89)

Disease	PMID	Source
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Ovarian cancer	22174824	CNVD
Urothelial carcinoma	18382360	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Biliary cancer	19435499	CNVD
Cancer	16751803	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	17387387	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	18923191	CNVD
Glioma	21971842	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
colon cancer	17210682	CNVD
Lung adenocarcinoma	21810691	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Colorectal cancer	19359472	CNVD
Hypothalamic hamartomas	18252217	CNVD
Human rectal carcinomas	16397240	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Medulloblastoma	18056178	CNVD
Basal cell lymphoma	17170743	CNVD
Ewing''s sarcoma	21437220	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Leukemia	23979775	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Autism	22495311	CNVD
Prostate cancer	16573809	CNVD
Acute myeloid leukemia	21251322	CNVD
Melanoma	17363583	CNVD
Kartagener syndrome	16639409	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	19242612	CNVD
Autism	18414403	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	21858162	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Cancer	21637783	CNVD
Squamous cell cancer	20885788	CNVD
Breast cancer	16397240	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Glioblastoma multiforme	18628472	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Heart disease	21282601	CNVD
Rubinstein-Taybi syndrome	22470819	CNVD
Alzheimer''s disease	22166940	CNVD
Abnormal phenotypes	18644119	CNVD
Non-syndromic sensorineural hearing loss	22570644	CNVD
Bladder cancer	21909424	CNVD
Cancer	21183584	CNVD
Autism	19492091	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	19805367	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:43 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:16168200-16170800	Enhancers	HSMM	muscle
2	chr7:16168600-16170600	Enhancers	HMEC	breast
3	chr7:16168600-16171000	Enhancers	HUVEC	blood vessel
4	chr7:16168800-16170600	Enhancers	NHLF	lung
5	chr7:16168800-16170800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
6	chr7:16169000-16170600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
7	chr7:16169600-16170600	Enhancers	NH-A	brain
8	chr7:16169600-16171000	Enhancers	NHDF-Ad	bronchial
9	chr7:16169600-16171200	Enhancers	Placenta Amnion	Placenta Amnion
10	chr7:16169800-16170600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
11	chr7:16169800-16170800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
12	chr7:16169800-16170800	Enhancers	HSMMtube	muscle
13	chr7:16169800-16183800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
14	chr7:16170000-16170600	Enhancers	Adipose Nuclei	Adipose
15	chr7:16170200-16170800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
16	chr7:16170200-16170800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
17	chr7:16170200-16171200	Enhancers	Fetal Muscle Leg	muscle
18	chr7:16170400-16170600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr7:16170400-16170600	Flanking Active TSS	Muscle Satellite Cultured Cells	--
20	chr7:16170400-16170600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
21	chr7:16170400-16170600	Flanking Active TSS	Osteobl	bone
22	chr7:16170400-16170800	Enhancers	Stomach Smooth Muscle	stomach
23	chr7:16170400-16171000	Enhancers	Skeletal Muscle Male	skeletal muscle
24	chr7:16170400-16171200	Enhancers	Placenta	Placenta
25	chr7:16170400-16171200	Enhancers	Psoas Muscle	Psoas
26	chr7:16170400-16171200	Enhancers	Right Atrium	heart
27	chr7:16170400-16171600	Enhancers	Left Ventricle	heart
28	chr7:16170400-16171600	Enhancers	Right Ventricle	heart
29	chr7:16170400-16171800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
30	chr7:16170400-16171800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
31	chr7:16170600-16170800	Enhancers	Osteobl	bone
32	chr7:16170600-16171200	Enhancers	Muscle Satellite Cultured Cells	--
33	chr7:16170600-16171400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
34	chr7:16170800-16174800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
35	chr7:16170800-16175400	Weak transcription	HSMMtube	muscle
36	chr7:16171000-16174800	Weak transcription	NHDF-Ad	bronchial
37	chr7:16171400-16175400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
38	chr7:16171800-16174400	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
39	chr7:16171800-16174800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
40	chr7:16174400-16175800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
41	chr7:16174800-16175200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
42	chr7:16174800-16175600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr7:16174800-16176800	Enhancers	NHDF-Ad	bronchial

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links